Valeura Energy Inc.: Q2 2024 Operations and Financial Update
Globe Newswire10-07-2024, 16:47
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab) 27-01-2025, 18:00